Surmodics, Inc. (FRA:SU6)

Surmodics Statistics

Total Valuation

Surmodics has a market cap or net worth of EUR 530.82 million.

Market Cap	530.82M
Enterprise Value	n/a

Important Dates

The last earnings date was Friday, November 21, 2025.

Earnings Date	Nov 21, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	14.30M
Shares Outstanding	n/a
Shares Change (YoY)	+0.87%
Shares Change (QoQ)	+0.02%
Owned by Insiders (%)	3.66%
Owned by Institutions (%)	83.14%
Float	14.26M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.91, with a Debt / Equity ratio of 0.29.

Current Ratio	3.91
Quick Ratio	2.88
Debt / Equity	0.29
Debt / EBITDA	3.72
Debt / FCF	-9.19
Interest Coverage	-0.41

Financial Efficiency

Return on equity (ROE) is -15.36% and return on invested capital (ROIC) is -0.61%.

Return on Equity (ROE)	-15.36%
Return on Assets (ROA)	-0.52%
Return on Invested Capital (ROIC)	-0.61%
Return on Capital Employed (ROCE)	-0.96%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	264,427
Profits Per Employee	-38,585
Employee Count	389
Asset Turnover	0.70
Inventory Turnover	1.84

Taxes

In the past 12 months, Surmodics has paid 2.50 million in taxes.

Income Tax	2.50M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +1.71% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+1.71%
50-Day Moving Average	26.02
200-Day Moving Average	27.03
Relative Strength Index (RSI)	82.62
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.03

Income Statement

In the last 12 months, Surmodics had revenue of EUR 102.86 million and -15.01 million in losses. Loss per share was -1.06.

Revenue	102.86M
Gross Profit	78.40M
Operating Income	-1.23M
Pretax Income	-12.51M
Net Income	-15.01M
EBITDA	5.98M
EBIT	-1.23M
Loss Per Share	-1.06

Balance Sheet

The company has 27.87 million in cash and 27.74 million in debt, with a net cash position of 124,319.

Cash & Cash Equivalents	27.87M
Total Debt	27.74M
Net Cash	124,319
Net Cash Per Share	n/a
Equity (Book Value)	94.78M
Book Value Per Share	6.63
Working Capital	48.15M

Cash Flow

In the last 12 months, operating cash flow was -1.60 million and capital expenditures -1.42 million, giving a free cash flow of -3.02 million.

Operating Cash Flow	-1.60M
Capital Expenditures	-1.42M
Free Cash Flow	-3.02M
FCF Per Share	n/a

Margins

Gross margin is 76.22%, with operating and profit margins of -1.20% and -14.59%.

Gross Margin	76.22%
Operating Margin	-1.20%
Pretax Margin	-12.16%
Profit Margin	-14.59%
EBITDA Margin	5.81%
EBIT Margin	-1.20%
FCF Margin	n/a

Dividends & Yields

Surmodics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.87%
Shareholder Yield	-0.87%
Earnings Yield	n/a
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Surmodics has an Altman Z-Score of 6.8 and a Piotroski F-Score of 2.

Altman Z-Score	6.8
Piotroski F-Score	2